ASIA PACIFIC GLUCOSE MONITORING SYSTEM MARKET FORECAST 2018-2026

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC GLUCOSE MONITORING SYSTEM MARKET FORECAST 2018-2026

ASIA PACIFIC GLUCOSE MONITORING SYSTEM MARKET FORECAST 2018-2026

The Asia Pacific Glucose Monitoring System Market raised $209.4 million in 2017. Between the forecast years of 2018-2026, the market is anticipated to rise with the CAGR of 36.69% and generate a net revenue of $3500.6 million. On the other hand, the Asia-Pacific Self-Monitoring of Blood Glucose (SMBG) market raised $2467 million in 2017. Between the forecasted, the market is anticipated to rise with the CAGR of 10.60% and generate a net revenue of $6026.4 million.

ASIA PACIFIC GLUCOSE MONITORING SYSTEM MARKET FORECAST 2018-2026

Asia Pacific Glucose Monitoring System Market (CGMS & SMBG) by Component Type (Sensors, Transmitters & Receivers, Insulin Pump) by Application (Home Settings, Diagnostics and Clinics, Hospitals) by Component Type (Test Strips, Glucose Meter) by Application (by Application, Clinics, Hospitals) by Geography.

Request free sample

The Asia-Pacific Continuous Glucose Monitoring System market (CGMS) raised $209.4 million in 2017. Between the forecast years of 2018-2026, the market is anticipated to rise with the CAGR of 36.69% and generate a net revenue of $3500.6 million.

On the other hand, the Asia-Pacific Self-Monitoring of Blood Glucose (SMBG) market raised $2467 million in 2017. Between the forecasted, the market is anticipated to rise with the CAGR of 10.60% and generate a net revenue of $6026.4 million.

Asia-Pacific Continuous Glucose Monitoring System Market

To learn more about this report, request a free sample copy

Asia Pacific has been anticipated to be the fastest growing region in the global CGMS and SMBG market. This is majorly due to countries like India and China, which have the largest diabetic population in the world. Thus, they are creating huge growth opportunities for the Glucose Monitoring System (GMS) market to flourish in this region. The urbanization, ageing, and lifestyle changes are the key determinants of the rapid increase in diabetic patients. China market had the highest revenue in the GMS market in 2017 and is expected to grow with the highest CAGR over the forecast period, followed by Japan, Australia, India, South Korea and the rest of the Asia-Pacific.

Companies like Terumo, Wockhardt, I-SENS Inc., Morpen Laboratories, Apex Biotechnology Corp., Arkray Inc., Shanghai Pharma, Carewell Biotech Pvt. Ltd., Pharmaco, etc. are leading this Glucose Monitoring Systems Market.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE STUDY MARKET
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
    • BOTTOM-UP APPROACH
    • TOP DOWN APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • CGMS MARKET IS ANTICIPATED TO BE A DEVELOPED MARKET
      • SELF-MONITORING OF BLOOD GLUCOSE HAS HUGE MARKET OPPORTUNITY
      • COLLABORATION OF SIGNIFICANT COMPANIES TO DEVELOP INTEGRATED CGMS-ENABLED INSULIN PUMPS
  1. MARKET OVERVIEW
    • DRIVERS AND IMPACT
      • RISE IN THE INCIDENCE OF DIABETES
      • INCREASE IN HEALTHCARE EXPENDITURE
      • INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
      • TECHNOLOGY INTEGRATION
      • INCREASING CGMS AND SMBG AFFORDABILITY
      • TECHNOLOGICAL ADVANCES IN GMS DEVICES
      • AWARENESS AMONG THE GENERAL POPULATION
    • RESTRAIN AND IMPACT
      • INADEQUATE REIMBURSEMENT OPTIONS FOR CONTINUOUS GLUCOSE MONITORING DEVICES
      • LACK OF AWARENESS ABOUT THE DIAGNOSTIC OPPORTUNITIES
    • CHALLENGES
      • INTENSE COMPETITION AMONG VENDORS
      • INACCURACY IN READING OF GMS DEVICES
      • INCREASINGLY STRINGENT GOVERNMENT REGULATIONS
  1. CGMS MARKET SEGMENTATION
    • MARKET BY COMPONENT TYPE 2018-2026
      • SENSORS
      • TRANSMITTERS AND RECEIVERS
      • INSULIN PUMP
    • MARKET BY END USERS 2018-2026
      • HOME SETTINGS
      • DIAGNOSTICS AND CLINICS
      • HOSPITALS
  1. SMBG MARKET
  2. SMBG MARKET SEGMENTATION
    • MARKET BY COMPONENT TYPE 2018-2026
      • TEST STRIPS
      • GLUCOSE METER
      • LANCETS
    • MARKET BY END USERS 2018-2026
      • HOME SETTINGS
      • CLINICS
      • HOSPITALS
  1. KEY ANALYTICAL
    • PORTER’S 5 FORCES ANALYSIS
      • THREAT OF NEW ENTRANT
      • THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • MERGER AND ACQUISITIONS
    • KEY BUYING CRITERIA
    • KEY TRENDS
      • DEVELOPMENT OF HIGH-QUALITY WEARABLE DEVICES
      • MOBILE HEALTHCARE MAKING THE DEVICES MORE USER-FRIENDLY
      • INCREASING EFFORTS TOWARDS SPREADING AWARENESS
      • INCREASE IN NON-INVASIVE DEVICES
      • ENERGY HARVESTING TECHNOLOGY FOR UNINTERRUPTED USAGE
    • REGULATION OF BLOOD SUGAR
    • INCIDENCE AND PREVALENCE OF DIABETES
  2. REGIONAL ANALYSIS
    • ASIA-PACIFIC (APAC)
      • CHINA
        • CHINA HEALTH AND HEALTHCARE
        • CHINA PHARMACEUTICAL MARKET
        • CHINA DIABETES MARKET
        • MARKET TRENDS
      • INDIA
        • INDIA HEALTH AND HEALTHCARE
        • INDIA REGULATORY CHANGES
        • INDIA PHARMACEUTICAL MARKET
        • INDIA DIABETES MARKET
        • MARKET TRENDS
      • AUSTRALIA
        • MARKET TRENDS
      • JAPAN
        • JAPAN HEALTH AND HEALTHCARE
        • JAPAN PHARMACEUTICAL MARKET
        • JAPAN DIABETES MARKET
        • MARKET TRENDS
      • SOUTH KOREA
        • MARKET TRENDS
      • INDONESIA
        • MARKET TRENDS
      • MALAYSIA
        • MARKET TRENDS
      • PHILIPPINES
        • MARKET TRENDS
      • THAILAND
        • MARKET TRENDS
      • VIET NAM
        • MARKET TRENDS
      • REST OF ASIA-PACIFIC (ROAP)
  1. COMPETITIVE LANDSCAPE
    • MEDTRONIC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • DEXCOM
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • ABBOTT
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • JOHNSON AND JOHNSON
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • INSULET CORP
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • TANDEM DIABETES CARE
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • ECHO THERAPEUTICS INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • ROCHE DIAGNOSTICS
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • NEMAURA MEDICAL INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • SENSEONICS INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • GLYSENS INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • TERUMO
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • WOCKHARDT
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • I-SENS INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
      • SCOT ANALYSIS
    • MORPEN LABORATORIES LTD.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVE
      • SCOT ANALYSIS
    • APEX BIOTECHNOLOGY CORP.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
    • ARKRAY INC
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC ANALYSIS
      • SCOT ANALYSIS
    • B BRAUN MELSUNGEN AG
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS
    • ASCENSIA
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC ANALYSIS

 

LIST OF TABLES

TABLE 1       ASIA PACIFIC CGMS MARKET, 2018-2026($ MILLION)

TABLE 2       ASIA PACIFIC SMBG MARKET, 2018-2026 ($ MILLION)

TABLE 3       ASIA PACIFIC CGMS MARKET, BY COMPONENT TYPE, 2018-2026($ MILLION)

TABLE 4       ASIA PACIFIC CGMS SENSORS MARKET, 2018-2026 ($ MILLION)

TABLE 5       ASIA PACIFIC CGMS TRANSMITTERS AND RECEIVERS MARKET,   2018-2026 ($ MILLION)

TABLE 6       ASIA PACIFIC CGMS INSULIN PUMP MARKET, 2018-2026 ($ MILLION)

TABLE 7       ASIA PACIFIC CGMS MARKET, BY APPLICATION 2018-2026 ($ MILLION)

TABLE 8       ASIA PACIFIC CGMS HOME SETTINGS MARKET, 2018-2026 ($ MILLION)

TABLE 9       ASIA PACIFIC CGMS DIAGNOSTICS AND CLINICAL MARKET, 2018-2026 ($ MILLION)

TABLE 10     ASIA PACIFIC CGMS HOSPITAL MARKET, 2018-2026 ($ MILLION)

TABLE 11     IMPORTANT ASPECTS FOR USE OF SMBG DEVICES IN HOME-CARE SETTINGS

TABLE 12     PRODUCT MATRIX FOR LANCETS

TABLE 13     ASIA PACIFIC SMBG MARKET, BY COMPONENT TYPE, 2018-2026 ($ MILLION)

TABLE 14     ASIA PACIFIC SMBG LANCETS MARKET, 2018-2026 ($ MILLION)

TABLE 15     ASIA PACIFIC SMBG HOME SETTING MARKET, 2018-2026 ($ MILLION)

TABLE 16     ASIA PACIFIC SMBG CLINICAL MARKET, 2018-2026 ($ MILLION)

TABLE 17     ASIA PACIFIC SMBG HOSPITALS MARKET, 2018-2026 ($ MILLION)

TABLE 18     ASIA PACIFIC SMBG MARKET, 2018-2026 ($ MILLION)

TABLE 19     ASIA PACIFIC CGMS MARKET REVENUE, 2018-2026($ MILLION)

TABLE 20     ASIA-PACIFIC SMBG MARKET REVENUE 2018-2026($ MILLION)

TABLE 21     AVERAGE PRICES IN CHINA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER

TABLE 22     CHINA SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE 23     AVERAGE PRICES IN INDIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 24     INDIA SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE 25     AVERAGE PRICES IN AUSTRALI FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 26     AUSTRALIA SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE 27     AVERAGE PRICES IN JAPAN FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 28     JAPAN SALES CHANNEL 2018-2026 ($ MILLION)

TABLE 29     AVERAGE PRICES IN SOUTH KOREA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 30     SOUTH KOREA SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE 31     AVERAGE PRICES IN INDONESIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 32     INDONESIA SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE 33     AVERAGE PRICES IN MALAYSIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 34     MALAYSIA SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE 35     AVERAGE PRICES IN PHILIPPINES FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 36     PHILIPPINES SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE 37     AVERAGE PRICES IN THAILAND FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 38     THAILAND SMBG SALES CHANNEL 2018-2026 ($ MILLION)

TABLE 39     AVERAGE PRICES IN VIETNAM FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 40     VIETNAM SMBG SALES CHANNEL 2018-2026 ($ MILLION)

 

LIST OF FIGURES

FIGURE 1     ASIA PACIFIC CGMS SENSORS MARKET, 2018-2026($ MILLION)

FIGURE 2     ASIA PACIFIC CGMS TRANSMITTERS AND RECEIVERS MARKET, 2018-2026($ MILLION)

FIGURE 3     ASIA PACIFIC CGMS INSULIN PUMP MARKET, 2018-2026($ MILLION)

FIGURE 4     ASIA PACIFIC CGMS SHARE, BY APPLICATION 2017 & 2026 (%)

FIGURE 5     ASIA PACIFIC CGMS HOME SETTING MARKET, 2018-2026($ MILLION)

FIGURE 6     ASIA PACIFIC CGMS DIAGNOSTICS AND CLINICAL MARKET, 2018-2026($ MILLION)

FIGURE 7     ASIA PACIFIC CGMS HOSPITAL MARKET, 2018-2026($ MILLION)

FIGURE 8     ASIA PACIFIC SMBG MARKET SHARE, BY COMPONENT TYPE 2017 & 2026(%)

FIGURE 9     ASIA PACIFIC SMBG TEST STRIPS MARKET, 2018-2026 ($ MILLION)

FIGURE 10   ASIA PACIFIC SMBG TEST STRIPS MARKET,  2018-2026 ($ MILLION)

FIGURE 11   ASIA PACIFIC SMBG GLUCOSE METER MARKET, 2018-2026 ($ MILLION)

FIGURE 12   ASIA PACIFIC SMBG GLUCOSE METER MARKET, 2018-2026 ($ MILLION)

FIGURE 13   ASIA PACIFIC SMBG LANCETS MARKET, 2018-2026 ($ MILLION)

FIGURE 14   ASIA PACIFIC SMBG MARKET SHARE, BY APPLICATION 2017& 2026(US $ MILLION)

FIGURE 15   ASIA PACIFIC SMBG HOME SETTING MARKET, 2018-2026 ($ MILLION)

FIGURE 16   ASIA PACIFIC SMBG CLINICAL MARKET, 2018-2026 ($ MILLION)

FIGURE 17   ASIA PACIFIC SMBG HOSPITALS MARKET, 2018-2026 ($ MILLION)

FIGURE 18   ASIA PACIFIC GGMS MARKET SHARE,  2017 & 2026 (%)

FIGURE 19   ASIA-PACIFIC CGMS MARKET REVENUE 2018-2026($ MILLION)

FIGURE 20   CHINA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 21   CHINA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 22   INDIA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 23   INDIA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 24   AUSTRALIA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 25   AUSTRALIA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 26   DEATHS IN AUSTRALIA DUE TO DIABETES

FIGURE 27   JAPAN CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 28   JAPAN  SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 29   SOUTH KOREA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 30   SOUTH KOREA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 31   INDONESIA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 32   INDONESIA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 33   MALAYSIA CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 34   MALAYSIA SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 35   PHILIPPINES CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 36   PHILIPPINES SMBG MARKET REVENUE, 2018-2026 ($ MILLION)

FIGURE 37   THAILAND CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 38   THAILAND SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 39   VIETNAM CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 40   VIETNAM SMBG MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 41   REST OF ASIA-PACIFIC CGMS MARKET REVENUE, 2018-2026($ MILLION)

FIGURE 42   REST OF ASIA-PACIFIC SMBG MARKET REVENUE, 2018-2026($ MILLION)

  1. REGIONAL ANALYSIS
    • ASIA-PACIFIC (APAC)
      • CHINA
        • CHINA HEALTH AND HEALTHCARE
        • CHINA PHARMACEUTICAL MARKET
        • CHINA DIABETES MARKET
        • MARKET TRENDS
      • INDIA
        • INDIA HEALTH AND HEALTHCARE
        • INDIA REGULATORY CHANGES
        • INDIA PHARMACEUTICAL MARKET
        • INDIA DIABETES MARKET
        • MARKET TRENDS
      • AUSTRALIA
        • MARKET TRENDS
      • JAPAN
        • JAPAN HEALTH AND HEALTHCARE
        • JAPAN PHARMACEUTICAL MARKET
        • JAPAN DIABETES MARKET
        • MARKET TRENDS
      • SOUTH KOREA
        • MARKET TRENDS
      • INDONESIA
        • MARKET TRENDS
      • MALAYSIA
        • MARKET TRENDS
      • PHILIPPINES
        • MARKET TRENDS
      • THAILAND
        • MARKET TRENDS
      • VIET NAM
        • MARKET TRENDS
      • REST OF ASIA-PACIFIC (ROAP)
  1. CGMS MARKET SEGMENTATION
    • MARKET BY COMPONENT TYPE 2018-2026
      • SENSORS
      • TRANSMITTERS AND RECEIVERS
      • INSULIN PUMP
    • MARKET BY END USERS 2018-2026
      • HOME SETTINGS
      • DIAGNOSTICS AND CLINICS
      • HOSPITALS
  1. SMBG MARKET SEGMENTATION
    • MARKET BY COMPONENT TYPE 2018-2026
      • TEST STRIPS
      • GLUCOSE METER
      • LANCETS
    • MARKET BY END USERS 2018-2026
      • HOME SETTINGS
      • CLINICS
      • HOSPITALS

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now